INmune Bio Inc. (INMB) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Inmune Bio Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.878 Greetings and welcome to the InMuneBio first quarter 2025 earnings call. 00:00:04.878 -- 00:00:07.903 At this time, all participants are in a listen-only mode. 00:00:07.903 -- 00:00:11.208 Later, you will have the opportunity to ask questions during the question and answer 00:00:11.208 -- 00:00:16.416 session. You may register to ask a question at any time by pressing star 1 on your telephone 00:00:16.416 -- 00:00:21.043 keypad. You may withdraw yourself from the queue by pressing star 2. 00:00:21.043 -- 00:00:23.607 As a reminder, this conference is being recorded. 00:00:23.607 -- 00:00:27.858 A transcript will follow within 24 hours of this conference call. 00:00:27.858 -- 00:00:31.263 At this time, it is my pleasure to introduce, excuse me, Mr. 00:00:31.263 -- 00:00:34.948 David Moss, CFO of ImmuneBio. David? 00:00:34.948 -- 00:00:37.651 Thank you, Jessie, and good afternoon, everyone. 00:00:37.651 -- 00:00:42.718 We thank you for joining us for the call for ImmuneBio's first quarter 2025 financial 00:00:42.718 -- 00:00:45.803 results. With me on the call today are Dr. 00:00:45.803 -- 00:00:51.030 RJ Tessie, CEO of ImmuneBio, and Dr. Mark Lodell, Chief Scientific Officer 00:00:51.030 -- 00:00:55.516 of ImmuneBio. We'll provide an update on our cords for many immune programs. 00:00:55.516 -- 00:01:00.400 Also on the call is Dr. C.J. Barnum, head of neuroscience, who will be here to answer 00:01:00.400 -- 00:01:01.802 questions. 00:01:01.802 -- 00:01:05.825 Before we begin, I remind everyone that except for statements of historical facts, the 00:01:05.825 -- 00:01:09.589 statements made by management and responses to questions on this conference call are 00:01:09.589 -- 00:01:14.133 forward-looking statements under the Safe Harbor...